Evidence map›Paper›PMID 29483183›Full record

ArticleDiabetes2018

HLA-B*07, HLA-DRB1*07, HLA-DRB1*12, and HLA-C*03:02 Strongly Associate With BMI: Data From 1.3 Million Healthy Chinese Adults.

Jie Shen, Tingwei Guo, Tao Wang, Yisong Zhen, Xiao Ma, Yuan Wang, Zhi-Xin Zhang, Jian-Ping Cai, Wei Mao, Fa-Ming Zhu and 41 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. A Novel Allele-Specific PCR Protocol for the Detection of theThe application of clinical genetics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

51 authors at 14 institutions in 2 countries.

Jie ShenThe Center of Immunological Genetics and HLA Typing, First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China shenjie@njmu.edu.cn tingwei.guo@einstein.yu.edu tingweiguo@gmail.com.
Tingwei GuoDepartment of Internal Medicine, First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China shenjie@njmu.edu.cn tingwei.guo@einstein.yu.edu tingweiguo@gmail.com.ORCID 0000-0002-9320-543X
Tao WangDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY.
Yisong ZhenState Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China.
Xiao MaThe Center of Immunological Genetics and HLA Typing, First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
Yuan WangFlow Cytometry Core Facility, Albert Einstein College of Medicine, Bronx, NY.
Zhi-Xin ZhangHLA Laboratory, Beijing Red Cross Blood Center, Beijing, China.
Jian-Ping CaiThe Key Laboratory of Geriatrics, Beijing Hospital, and Beijing Institute of Geriatrics, Ministry of Health, Beijing, China.
Wei MaoHLA Laboratory, Chongqing Blood Center, Chongqing, China.
Fa-Ming ZhuHLA Laboratory, Zhejiang Blood Center, Hangzhou, Zhejiang, China.
Jian-Ping LiHLA Laboratory, Liaoning Blood Center, Shenyang, Liaoning, China.
Zhen-Lei WangHLA Laboratory, Hebei Blood Center, Shijiazhuang, Hebei, China.
De-Mei ZhangHLA Laboratory, Taiyuan Red Cross Blood Center, Taiyuan, Shanxi, China.
Meng-Li LiuHLA Laboratory, Shaanxi Blood Center, Xi'an, Shaanxi, China.
Xiao-Yan ShanHLA Laboratory, Beijing Red Cross Blood Center, Beijing, China.
Bo-Wei ZhangHLA Laboratory, Henan Blood Center, Zhengzhou, Henan, China.
Chuan-Fu ZhuHLA Laboratory, Shandong Blood Center, Jinan, Shandong, China.
Zhi-Hui DengThe Key Laboratory of Histocompatibility and Immunogenetics, Shenzhen Blood Center, Shenzhen, Guangdong, China.
Wei-Jian YuHLA Laboratory, Dalian Red Cross Blood Center, Dalian, Liaoning, China.
Qiang ChenHLA Laboratory, Institute of Blood Transfusion, Chinese Academy of Medical Sciences, and Peking Union Medical College, Chengdu, Sichuan, China.
Guo-Liang LiHLA Laboratory, Jiangxi Blood Center, Nanchang, Jiangxi, China.
Tao YangDepartment of Endocrinology and Metabolism, First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
Shan LuDepartment of Health Education, First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
Qin-Qin PanThe Center of Immunological Genetics and HLA Typing, First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
Su FanThe Center of Immunological Genetics and HLA Typing, First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
Xiao-Yan WangThe Center of Immunological Genetics and HLA Typing, First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
Xing ZhaoThe Center of Immunological Genetics and HLA Typing, First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
Xin-Yun BiThe Center of Immunological Genetics and HLA Typing, First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
Yan-Hui QiaoHLA Laboratory, Xinjiang Blood Center, Urumchi, Xinjiang, China.
Pin-Can SuHLA Laboratory, Kunming Blood Center, Kunming, Yunnan, China.
Rong LvHLA Laboratory, Hefei Red Cross Blood Center, Hefei, Anhui, China.
Guo-Ying LiHLA Laboratory, Gansu Red Cross Blood Center, Lanzhou, Gansu, China.
Heng-Cong LiHLA Laboratory, Nanning Blood Center, Nanning, Guangxi, China.
Bin PeiHLA Laboratory, Xiamen Blood Center, Xiamen, Fujian, China.
Li-Xin JiaoHLA Laboratory, Changchun Blood Center, Changchun, Jilin, China.
Gang ShenHLA Laboratory, Wuhan Blood Center, Wuhan, Hubei, China.
Jie LiuHLA Laboratory, Harbin Red Cross Blood Center, Harbin, Heilongjiang, China.
Zhi-Hui FengHLA Laboratory, Qingdao Blood Center, Qingdao, Shandong, China.
Yu-Ping SuHLA Laboratory, Yueyang Red Cross Blood Center, Yueyang, Hunan, China.
Yu-Bin XieHLA Laboratory, Changsha Blood Center, Changsha, Hunan, China.
Wen-Ying DiHLA Laboratory, Soochow Red Cross Blood Center, Suzhou, Jiangsu, China.
Xin-Yu WangDepartment of Endocrinology, First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China.
Xiang LiuHLA Laboratory, CapitalBio Corporation, Beijing, China.
Xiao-Ping ZhangHLA Laboratory, Beijing Genomics Institute, Shenzhen, Guangdong, China.
Dan DuDepartment of HLA Technology, China Bone Marrow Program, Beijing, China.
Qi LiuDepartment of HLA Technology, China Bone Marrow Program, Beijing, China.
Ying HanDepartment of HLA Technology, China Bone Marrow Program, Beijing, China.
Jia-Wei ChenDepartment of Endocrinology and Metabolism, First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
Min GuDepartment of Urology, First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
Leslie J BaierPhoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
China Marrow Donor Program
Nanjing Medical University · CNBeijing Red Cross Blood Center · CNAlbert Einstein College of Medicine · USChinese Academy of Medical Sciences & Peking Union Medical College · CNShenzhen University · CNBeijing Hospital · CNBGI Group (China) · CNBlood Center of Zhejiang Province · CNNational Institutes of Health · USQingdao Center of Resource Chemistry and New Materials · CNShaanxi Blood Center · CNShenzhen Blood Center · CNWuhan Blood Center · CNXiamen Blood Center · CN

Funding

Follow-Up Studies of a Genome-Wide Association Analysis in Pima IndiansZIADK075012 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI BAIER, LESLIE J · 2009 to 2025
$17.9M
Structural Analysis Of Candidate Genes For Type 2 Diabetes and ObesityZIADK069071 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI BAIER, LESLIE J · 2009 to 2025
$15.4M
6 · The paper itself

Abstract

Strong associations between HLA alleles and infectious and autoimmune diseases are well established. Although obesity is also associated with these diseases, the relationship between HLA and obesity has not been systematically investigated in a large cohort. In the current study, we analyzed the association of HLA alleles with BMI using data from 1.3 million healthy adult donors from the Chinese Marrow Donor Program (CMDP). We found 23 HLA alleles, including 12 low-resolution and 11 high-resolution alleles, were significantly associated with BMI after correction for multiple testing. Alleles associated with high BMI were enriched in haplotypes that were common in both Chinese and European populations, whereas the alleles associated with low BMI were enriched in haplotypes common only in Asians. Alleles B*07, DRB1*07, DRB1*12, and C*03:02 provided the strongest associations with BMI (

Indexed as

AdolescentAdultAsian PeopleBody Mass IndexChinaFemaleGenotypeHLA-B7 AntigenHLA-C AntigensHLA-DRB1 ChainsHumansMaleMiddle AgedObesityOverweightPhenotypeHLA-B*07 antigenHLA-B7 AntigenHLA-C*03 antigenHLA-C AntigensHLA-DRB1*07 antigenHLA-DRB1 Chains

Identifiers

PMID29483183
PMCPMC6463754
OpenAlexW2790395105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.